Autoimmunity to the sodium-level sensor in the brain causes essential hypernatremia

Neuron

Volumn 66, Issue 4, 2010, Pages 508-522

  Hiyama, Takeshi Y ^a   Matsuda, Shinichi ^b   Fujikawa, Akihiro ^a   Matsumoto, Masahito ^a   Watanabe, Eiji ^a   Kajiwara, Hiroshi ^b   Niimura, Fumio ^b   Noda, Masaharu ^a  

^a GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cellimmuno; Humdisease; Molneuro

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3; HYPOTONIC SOLUTION; IMMUNOGLOBULIN; SODIUM; SODIUM AUTOANTIBODY; UNCLASSIFIED DRUG; VASOPRESSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; BRAIN REGION; CASE REPORT; CAUSAL ATTRIBUTION; CHILD; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DIURESIS; ESSENTIAL HYPERNATREMIA; FEMALE; FLUID INTAKE; GANGLIONEUROMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERNATREMIA; INFLAMMATORY INFILTRATE; MALE; MOUSE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RAT; SALT INTAKE; SCHWANN CELL; SIGNAL DETECTION; SODIUM BLOOD LEVEL; TISSUE SPECIFICITY; VASOPRESSIN RELEASE;

EID: 77953263987     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2010.04.017     Document Type: Article

References (53)

1. Adrogué H.J., Madias N.E. Hypernatremia. N. Engl. J. Med. 2000, 342:1493-1499.
2. Andersson B., Leksell L.G., Rundgren M. Regulation of water intake. Annu. Rev. Nutr. 1982, 2:73-89.
3. Avioli L.V., Earley L.E., Kashima H.K. Chronic and sustained hypernatremia, absence of thirst, diabetes insipidus, and adrenocorticotrophin insufficiency resulting from widespread destruction of the hypothalamus. Ann. Intern. Med. 1962, 56:131-140.
4. Bappal B., Sheikh H.A., Radhakrishan A., Mula-Abed W.A. Adipsic hypernatremia with a reset osmostat. Saudi Med. J. 2006, 27:727-729.
5. Baylis P.H., Thompson C.J. Osmoregulation of vasopressin secretion and thirst in health and disease. Clin. Endocrinol. (Oxf.) 1988, 29:549-576.
6. Beckh S., Noda M., Lübbert H., Numa S. Differential regulation of three sodium channel messenger RNAs in the rat central nervous system during development. EMBO J. 1989, 8:3611-3616.
7. Bourque C.W. Central mechanisms of osmosensation and systemic osmoregulation. Nat. Rev. Neurosci. 2008, 9:519-531.
8. Broadwell R.D., Sofroniew M.V. Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system. Exp. Neurol. 1993, 120:245-263.
9. Cauble M.S., Mack-Shipman L., Schaefer G.B., Balakrishnan S., Larsen J.L. Idiopathic hypothalamic dysfunction with precocious puberty and adipsic hypernatremia first presenting in adolescence. J. Pediatr. Endocrinol. Metab. 2001, 14:1163-1167.
10. Ciura S., Bourque C.W. Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality. J. Neurosci. 2006, 26:9069-9075.
11. Conley S.B., Brocklebank J.T., Taylor I.T., Robson A.M. Recurrent hypernatremia; a proposed mechanism in a patient with absence of thirst and abnormal excretion of water. J. Pediatr. 1976, 89:898-903.
12. Dalmau J., Gleichman A.J., Hughes E.G., Rossi J.E., Peng X., Lai M., Dessain S.K., Rosenfeld M.R., Balice-Gordon R., Lynch D.R. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008, 7:1091-1098.
13. Damoiseaux J.G., Döpp E.A., Calame W., Chao D., MacPherson G.G., Dijkstra C.D. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 1994, 83:140-147.
14. Darnell R.B., Posner J.B. Paraneoplastic syndromes affecting the nervous system. Semin. Oncol. 2006, 33:270-298.
15. de Torres C., Munell F., Ferrer I., Reventós J., Macaya A. Identification of necrotic cell death by the TUNEL assay in the hypoxic-ischemic neonatal rat brain. Neurosci. Lett. 1997, 230:1-4.
16. DeRubertis F.R., Michelis M.F., Davis B.B. "Essential" hypernatremia. Report of three cases and review of the literature. Arch. Intern. Med. 1974, 134:889-895.
17. Drachman D.B., Angus C.W., Adams R.N., Michelson J.D., Hoffman G.J. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N. Engl. J. Med. 1978, 298:1116-1122.
18. duRivage S.K., Winter R.J., Brouillette R.T., Hunt C.E., Noah Z. Idiopathic hypothalamic dysfunction and impaired control of breathing. Pediatrics 1985, 75:896-898.
19. Goldin A.L., Barchi R.L., Caldwell J.H., Hofmann F., Howe J.R., Hunter J.C., Kallen R.G., Mandel G., Meisler M.H., Netter Y.B., et al. Nomenclature of voltage-gated sodium channels. Neuron 2000, 28:365-368.
20. Greaves D.R., Gordon S. Macrophage-specific gene expression: current paradigms and future challenges. Int. J. Hematol. 2002, 76:6-15.
21. Hayek A., Peake G.T. Hypothalamic adipsia without demonstrable structural lesion. Pediatrics 1982, 70:275-278.
22. x channel involved in CNS sodium-level sensing. Nat. Neurosci. 2002, 5:511-512.
23. x sodium channels for the control of salt-intake behavior. J. Neurosci. 2004, 24:9276-9281.
24. Lang B., Newsom-Davis J., Wray D., Vincent A., Murray N. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet 1981, 2:224-226.
25. Liedtke W. Molecular mechanisms of TRPV4-mediated neural signaling. Ann. N. Y. Acad. Sci. 2008, 1144:42-52.
26. Liedtke W., Choe Y., Martí-Renom M.A., Bell A.M., Denis C.S., Sali A., Hudspeth A.J., Friedman J.M., Heller S. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 2000, 103:525-535.
27. Lin M., Liu S.J., Lim I.T. Disorders of water imbalance. Emerg. Med. Clin. North Am. 2005, 23:749-770, ix.
28. Mangiapane M.L., Thrasher T.N., Keil L.C., Simpson J.B., Ganong W.F. Role for the subfornical organ in vasopressin release. Brain Res. Bull. 1984, 13:43-47.
29. Mix E., Goertsches R., Zett U.K. Immunoglobulins-basic considerations. J. Neurol. 2006, 253(Suppl 5):V9-V17.
30. x-deficient mice show normal vasopressin response to dehydration. Neurosci. Lett. 2010, 472:161-165.
31. Nauta A.J., Daha M.R., Tijsma O., van de Water B., Tedesco F., Roos A. The membrane attack complex of complement induces caspase activation and apoptosis. Eur. J. Immunol. 2002, 32:783-792.
32. Noda M. The subfornical organ, a specialized sodium channel, and the sensing of sodium levels in the brain. Neuroscientist 2006, 12:80-91.
33. Noda M. Hydromineral neuroendocrinology: mechanism of sensing sodium levels in the mammalian brain. Exp. Physiol. 2007, 92:513-522.
34. Noda M., Hiyama T.Y. Sodium-level-sensitive sodium channel and salt-intake behavior. Chem. Senses 2005, 30(Suppl 1):i44-i45.
35. Palevsky P.M. Hypernatremia. Semin. Nephrol. 1998, 18:20-30.
36. Ross E.J., Christie S.B. Hypernatremia. Medicine (Baltimore) 1969, 48:441-473.
37. 12 in microglia in rat brain. Glia 2003, 44:242-250.
38. Schaad U., Vassella F., Zuppinger K., Oetliker O. Hypodipsia-hypernatremia syndrome. Helv. Paediatr. Acta 1979, 34:63-76.
39. +] sensing. Neuron 2007, 54:59-72.
40. Sillevis Smitt P., Kinoshita A., De Leeuw B., Moll W., Coesmans M., Jaarsma D., Henzen-Logmans S., Vecht C., De Zeeuw C., Sekiyama N., et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N. Engl. J. Med. 2000, 342:21-27.
41. Takamori M., Hamada T., Komai K., Takahashi M., Yoshida A. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats. Ann. Neurol. 1994, 35:74-80.
42. Thrasher T.N., Keil L.C., Ramsay D.J. Lesions of the organum vasculosum of the lamina terminalis (OVLT) attenuate osmotically-induced drinking and vasopressin secretion in the dog. Endocrinology 1982, 110:1837-1839.
43. Tsokos G.C. Complement in Autoimmunity 2003, Karger Pub, Basel.
44. Unal Cevik I., Dalkara T. Intravenously administered propidium iodide labels necrotic cells in the intact mouse brain after injury. Cell Death Differ. 2003, 10:928-929.
45. Vernino S. Autoimmune and paraneoplastic channelopathies. Neurotherapeutics 2007, 4:305-314.
46. Vernino S., Ermilov L.G., Sha L., Szurszewski J.H., Low P.A., Lennon V.A. Passive transfer of autoimmune autonomic neuropathy to mice. J. Neurosci. 2004, 24:7037-7042.
47. Vincent A., Lang B., Kleopa K.A. Autoimmune channelopathies and related neurological disorders. Neuron 2006, 52:123-138.
48. Votey S.R., Peters A.L., Hoffman J.R. Disorders of water metabolism: hyponatremia and hypernatremia. Emerg. Med. Clin. North Am. 1989, 7:749-769.
49. v2/NaG channel is involved in control of salt-intake behavior in the CNS. J. Neurosci. 2000, 20:7743-7751.
50. X sodium channel is expressed in non-myelinating Schwann cells and alveolar type II cells in mice. Neurosci. Lett. 2002, 330:109-113.
51. x is expressed in glial laminate processes in the sensory circumventricular organs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R568-R576.
52. Welt L.G. Hypo- and hypernatremia. Ann. Intern. Med. 1962, 56:161-164.
53. Zhou C.C., Zhang Y., Irani R.A., Zhang H., Mi T., Popek E.J., Hicks M.J., Ramin S.M., Kellems R.E., Xia Y. Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat. Med. 2008, 14:855-862.